Benign rat mammary epithelial cells transfected with restriction enzyme-fragmented DNA from a human malignant metastatic cell line (Ca2-83) produces transfectants that yield metastatic tumours in syngeneic rats. The six metastasis-inducing DNAs (Met-DNAs) that have been isolated from such transfectants are subgene in size and do not code for any expressed mRNAs, but correspond to potential regulatory regions of human DNA from malignant, metastatic cells. In pilot studies the one Met-DNA tested is detectable in some human breast tumours but not in normal tissue. Transfection of all six Met-DNAs singly into the benign mammary epithelial cells causes enhanced expression of osteopontin, whilst transfection of cDNA for osteopontin also induces the metastatic state. These results show that short regulatory DNAs exist in human cancer cells that can induce metastatic spread via a common eector gene, osteopontin, in model rat mammary cell lines.
Introduction
The major forms of cancer, including the breast cannot be cured because, although the current therapies are eective against the primary tumours, they are largely ineective against the disseminating or metastasizing cells, which ultimately kill the patient (Kamby, 1990) . However, despite its importance, very little is known at the molecular level about the process of metastasis. Most of the oncogenes that have been discovered so far have been found from their ability to promote uncontrolled growth of a mouse ®broblast cell line Shih et al., 1981) , an assay that does not measure the process of metastasis directly. In fact, although uncontrolled growth is an important aspect of initial events in the development of a cancer, the rate of growth of distant metastases can be remarkably slow (Kamby, 1990) .
Most primary tumours, including those of the breast (Kamby, 1990; Liotta et al., 1991) are thought to arise in a benign proliferative form and, at a later stage in development, to acquire multiple genetic alterations that promote dissemination and metastasis (Nowell, 1976; Fidler and Kripke, 1977; Poste and Fidler, 1981; Fisher and Cifone, 1981; Thorgeirsson et al., 1985) . To identify those genetic alterations which are important in promoting metastasis in a dominant manner, we have transfected a stably diploid rat mammary epithelial cell line (Rama 37) that makes benign, nonmetastasizing tumours in syngeneic rats (Dunnington et al., 1983) with restriction enzyme-fragmented DNA from various rat and human cell lines. Only those benign Rama 37 cells transfected with DNA from malignant metastatic cell lines produce transfectants that yield metastatic tumours when injected subcutaneously in the mammary glands of syngeneic rats (Jamieson et al., 1990a,b; Davies et al., 1994) consistent with reports in other transfected-cell systems (Anathawaswamy et al., 1988; Tarin, 1988; RadlerPohl et al., 1988; Gibbins et al., 1991) . Here we have isolated and cloned the human DNAs responsible for inducing metastasis in this experimental system. The metastasis-inducing DNAs do not code for any expressed genes but probably correspond to dierent regulatory regions of human DNA. They all, however, exert their eect in the model system by upregulating the expression of a rat gene product which is probably the direct eector of metastasis in this system.
Results

Transfer of metastasizing ability by tagged fragments of human DNA
Cotransfection of the benign non-metastatic rat mammary cell line, Rama 37, with pSV2neo and HindIII-fragmented DNA from a human malignant metastatic breast cancer cell line (Ca2-83) yields a small proportion (1 ± 3%) of malignant transfectants which metastasize when introduced into the mammary glands of syngeneic female rats. In contrast, cotransfection of Rama 37 cells with pSV2neo and similarly-fragmented DNA from a cell line isolated from a benign nonmetastatic human breast lesion (HMT-3522) yields benign transfectants which do not metastasize in syngeneic rats. A cell line from a lung metastasis (R37-Ca2-LT1) arising from the former transfectants and a cell line (R37-B-T1) from the benign primary tumour arising from the latter transfectants retain their metastasizing and benign features, respectively, when introduced into the mammary fat pads of syngeneic Furth-Wistar rats (Table 1) . This demonstrates that in this system, as in others, metastasizing ability can be transferred in a genetically dominant manner.
To aid rescue of the human DNA sequences transferred in this manner, the DNAs from the metastatic (R37-Ca2-LT1) and benign (R37-B-T1) cell lines, fragmented with restriction enzyme HindIII have been tagged at both ends with double-stranded synthetic oligodeoxynucleotides that provide restriction enzyme and unique polymerase chain reaction (PCR) primer sites ( Figure 1 ). Cotransfection of Rama 37 cells with tagged or untagged genomic DNA fragments and pSV2neo has generated three new types of cell line: (a) R37-Ca2-HT produced by transfecting Rama 37 cells with the tagged HindIII DNA fragments from the metastatic transformant cell line R37-Ca2-LT1 derived from the lung metastasis; (b) R37-Ca2-H produced by transfecting Rama 37 cells with the same HindIII-fragmented DNA but not linked to tags; and (c) R37-B-HT produced by transfecting Rama 37 cells with HindIII-fragmented and tagged DNA from the benign cell line R37-B-T1. Southern blot hybridisations con®rm that the DNA incorporated into the genomic DNA of R37-Ca2-HT and R37-B-HT has tags attached but that of the R37-Ca2-H cell lines does not, as anticipated (not shown). When injected into the mammary fat pads of syngeneic rats, only those cell lines containing the Ca2-DNA fragments whether tagged or untagged yield signi®cant numbers of metastases in the lungs. Thus tagging has little eect on the incidence of metastasis (Table 1) .
Isolation of metastasis-inducing human DNAs
Cell lines have been established from the culture of a lung metastasis from the tagged, transfected group of rats and genomic DNA isolated. PCR ampli®cation of the DNA between the tags using primers from tag positions 3 to 24 ( Figure 1a ) yields two broad bands (F1 and F2) of about 900 and 1100 bp on agarose gel electrophoresis (not shown). Separation of these ampli®ed DNA fragments, cotransfection with pSV2neo into Rama 37 cells and reintroduction of the resultant transformants into syngeneic rats yields signi®cant numbers of lung metastases for both F1 and F2 (Table 1) . DNA fragments, F1 and F2 were pooled and cloned directly in a plasmid vector (Materials and methods). Thirty randomly picked recombinant plasmids contain DNA inserts of about 1000 bp ( Figure  1b ), but each insert belonged to one of only six dierent sequence groups termed C2, C5, C6, C9, C12 and C20-DNA (UK Patent Application 9600479.0). Cotransfection of representatives of these six sequence groups into Rama 37 cells with pSV2neo and reintroduction of the resultant transfectants into syngeneic rats, con®rm that all six fragments produce lung metastases, although the frequency varies from 12 ± 50% depending on the sequence (Table 2) . A few metastases to lymph nodes have also been noted, but no metastatic deposits have been observed in other organs (not shown). All metastases have been identi®ed by visual inspection and con®rmed by histology and by culturing cell lines in neo-selecting medium. A cell line developed from a lung metastasis of C9-DNA transfectants produces tumours which metastasize at higher frequency than the parental transformants when reintroduced into syngeneic rats ( Table 2) .
Identi®cation of metastasis-inducing DNA sequence(s) in transfected rat cells and in human breast tumours
It is possible that the metastasis-inducing properties of the cloned metastasis-inducing DNAs arises from disruption of the genome by widespread integration of the transfected DNA. The DNA of the C9-DNA transfectants has, therefore, been digested with HindIII and electrophoresed on agarose gels. Bands of greater than 23 kbp which hybridise to the C9-DNA probe have been obtained (Figure 2 ), and pulsed-®eld gel electrophoresis yields multiple bands of about 16 ± 48 kbp. This result strongly suggests that the¯anking HindIII sites have been destroyed by the transfection/ integration process. The highest 48 kbp band is preferentially retained by the cell line isolated from a lung metastasis ( Figure 2b ); thus it is likely that this represents most of the metastasis-inducing DNA. The C9-DNA transfectants contain about 100 copies per haploid genome of C9-DNA when compared with a single copy ( Figure 2a , lane P), 10 copy and a 100 copy DNA control. PCR ampli®cation of the integrated DNA using primers complementary to the cDNA adjacent to the untagged ends of C9-DNA produces a single 1 kbp product showing that the integrity between the primer sites has been maintained ( Figure  2c ). However, digestion of the DNA of C9-DNA transfectants with EcoRI (which cuts once internally within the C9-DNA) and hybridisation with a C9-DNA speci®c probe yields predominantly a 1 kbp band of similar size to the original C9-DNA insert ( Figure  2d ). This 1 kbp band probably arises from the digestion of tandem repeats of C9-DNA. Similar results have been obtained with C2, C5, C6, C12 and C20-DNAs.
The occurrence of C9-DNA has been investigated in pilot studies in the DNA of human breast cancers. Hybridisation of C9-DNA occurs to HindIII-digested DNA from four out of the nine breast tumours tested, whereas no hybridisation signal is detected from similarly-digested DNA from normal human breast or colon tissue. In this case a single hybridising band of 1000 bp is detected (Figure 3) . Similar results for C9-DNA have been obtained using PCR.
Mechanism of action of metastasis-inducing DNAs
Although most of the DNA sequences of the metastasisinducing (Met)-DNAs possess potential open reading frames, none code for any known human or rodent proteins (Materials and methods). The Rama 37 cells transfected with the cloned C9-DNA or its precursors also fail to express any mRNAs that can detectably hybridise to the C9-DNA probe, although in controls the C9-DNA probe can hybridise with T7 RNA polymerasetranscribed C9-RNA (Figure 4a ). Similar results have been obtained for all the transformants tested, viz., C2, C5 and C12-DNA. Detailed examination of their DNA sequences has con®rmed that the six Met-DNAs bear no relationship to one another. C6-DNA shows 86% homology to 102 bp of the rat WAP promoter (Cambell and Rosen, 1984) with a novel duplication of 30 nucleotides of this region. All Met-DNAs contain recognition sequences for transcription factors TCF-1 (van de Wetering et al., 1991) and HIPlb (Means and Farnham, 1990) . Moreover all but one contain recognition sequences for CTCF (Lobanenkov et al., 1990) , HIPla (Means and Farnham, 1990) , NF-IL6 (Majello et al., 1990) and regions of potential Z-DNA (Wang et al., 1979) , with C6-DNA containing a tract of 23 alternating purine-pyrimidine bases. Thus these novel sequences all contain potential regulatory regions for transcription of DNA into mRNA but no known coding or viral-related sequences.
In subtractive hybridisation studies, about 25% of the dierentially subtracted mRNAs between the parental metastatic cell line R37-Ca2-LT1 and the untransfected benign Rama 37 cells are due to the upregulation of osteopontin opn (Oates et al., 1996) . The precursor metastatic F1-and F2-DNA transfected cells (not shown) as well as all the Met-DNA transfected cells show increased levels of opn mRNA relative to that in the benign Rama 37 cells (Figure 4b ). These increases range from 1.6-fold in uncloned C5-and C6-DNA transfected cells to 4.4-fold in uncloned C9-DNA transfected cells (Table 2 ). This ratio rises to 16-fold in a cloned cell line isolated from a lung metastasis of C9-DNA transfectants injected into syngeneic rats (Table 2) . Transfection of Rama 37 cells by the rat opn cDNA under the control of a cytomegalovirus promoter in an expression plasmid produces transfectants with a sixfold elevated level of rat opn mRNA. When these transfectants are injected into syngeneic rats, they also induce a high frequency of metastasis. Control cells transfected with the expression vector alone produce transfectants with no elevated levels of opn mRNA and which fail to induce metastasis at all when introduced into rats ( Table 2 ). The opn is also expressed in those tumours in vivo which are produced by the transfected cell lines which show elevated levels of opn mRNA in vitro. Thus b Transfectants were tested for their level of opn mRNA relative to that in Rama 37 cells by Northern hybridisations using a Shimadzu CS9000 scanning densitomer. RNA loading levels were standardised with respect to a 36B4 ribosomal protein constitutive probe (Materials and methods).
c Transfectants were tested in the mammary glands of rats for the percentage (%) of tumour-bearing animals with metastases in the lungs (Materials and methods). The incidence of tumours produced by all transfectants was 100%.
d Signi®cantly higher levels than for Rama 37 cells (P50.05; Mann Whitney U test).
e Signi®cantly more metastases than for Rama 37 cells (P50.05; Fisher exact test) benign Rama 37-induced tumours in the rats fail to stain immunocytochemically with antibodies to rat opn, whilst the original metastatic transfectant's (R37-Ca2-LT1) (Oates et al., 1996) , C9-DNA cell-induced ( Figure  5a ) and opn cell-induced (Oates et al., 1996) lung metastases are stained to a similar degree to one another. In controls there was no immunocytochemical staining for opn of lung metastases produced by injection of Rama 37 cells transfected with an unrelated gene, that for p9Ka (Figure 5b ).
Discussion
Although the results presented here for the isolation of metastasis-inducing DNAs have been obtained from only one malignant metastatic breast cell line Ca2-83, DNAs with similar ability occur in MCF-7 (Soule et al., 1973) and ZR-75 (Engel et al., 1978) breast carcinoma cell lines isolated from metastatic pleural eusions (Davies et al., 1994) and from metastatic rat mammary cell lines (Jamieson et al., 1990a) . Moreover the one Met-DNA tested, C9-DNA, preferentially occurs in genomic DNA from some, but not all, breast tumours but not in genomic DNA from normal tissue. The number of copies of integrated Met-DNAs in the transformants is of the order of 100 per haploid genome, as determined by comparison with standard copy number controls, many in the form of apparently HindIII-resistant, but EcoRI digestible, tandemlyrepeated 1 kbp units of 40 ± 50 kbp. This result suggests that the Met-DNAs are largely integrated as large concatenates at relatively few sites in the genome of the transfected Rama 37 cells, consistent with our previous results from the transfection of de®ned genes or pSV2neo alone in these systems (Jamieson et al., 1990a,b; Davies et al., 1994) . The pilot studies with clinical breast material suggest that the number of integrated copies is much lower. However, integration of such high copy numbers of transfected DNAs into the transformant cells is not, in itself, sucient to induce metastatic ability, since similar copy numbers of integrated pSV2neo alone fail to induce metastasis in this system (Jamieson et al., 1990a; Davies et al., 1994) . That the Met-DNAs probably correspond to regulatory regions of DNA is consistent with the high frequency (1 ± 3%) of single-cell derived colonies of metastatic transformants produced from the original metastatic cell lines in this (Jamieson et al., 1990a; Davies et al., 1994) and in other systems (Anathawaswamy et al., 1988; Tarin, 1988; Radler-Pohl et al., 1988; Gibbins et al., 1991) . It is highly unlikely that dierences in metastatic ability may be due to dierences in immunological recognition of human sequences in the rat cells, since such dierences in metastatic ability are found in DNA from benign and metastatic rat cells syngeneic with the animals used for such test purposes (Jamieson et al., 1990a) and as shown here the integrated Met-DNA sequences are not expressed in these rat systems. How the Met-DNAs arose preferentially in the original malignant metastatic cells is unknown, but it is possible that what appears as a 1 kbp HindIII fragment is actually the result of a deletion or rearrangement bringing together two smaller fragments which were not detectable separately by Southern blotting of DNA from normal tissue.
Our previous subtractive hybridisation experiments between the benign and the original human metastatic DNA-transfected rat cell lines have shown that opn mRNA represents by far and away the largest abundance of any altered mRNA using this technique. The other four mRNAs which change appreciably P]ribosomal protein 36B4 cDNA for standardisation purposes. Bound radioactivity was detected on X-ray ®lm. In (a) the total RNA was either synthesised from phage T7-transcribed C9-DNA as a control (C9 DNA) or was isolated from the metastatic C9-DNA transfected Rama 37 cells (R37C9) ( Table 2) , and its precursor metastatic transformants R37-F1 (R37F1), R37-F2 (R37F2), R37-Ca2-HT (R37HT), nonmetastatic transformant R37-B-HT (R37BHT) (all in Table 1 ) and the parental nonmetastatic Rama 37 cells (R37). In (b) the total RNA was isolated from the parental nonmetastatic Rama 37 cells (R37), the benign control R37-B-HT (R37BHT) ( Table 1) , metastatic C2-DNA (R37C2), C5-DNA (R37C5), C6-DNA (R37C6), C9-DNA (R37C9), C12-DNA (R37C12), C20-DNA (R37-C20) transfected Rama 37 cells and a metastatic cell line from a lung metastasis of C9-DNA transfectants (R37C9Lu) (all in are present in lower abundances and are related to housekeeping genes unconnected with transformation and metastasis (Oates et al., 1996) . In this paper although the six Met-DNAs show little sequence homology to one another, all their transfectants exhibit elevated levels of opn mRNA. These elevated levels are increased a further three ± fourfold for a clonal cell line isolated from a lung metastasis produced by C9-DNA transfectants and the metastasizing ability of the same cell line is increased by about a further twofold. However, selection for lung metastases per se does not invariably generate increased levels of opn mRNA, since lung metastases produced by the metastasis-inducing gene for p9Ka (Barraclough et al., 1987) fail to show elevated levels of opn (Oates et al., 1996) . Since overproduction of rat opn mRNA by similar amounts in Rama 37 cells transfected with opn cDNA also causes these cells to metastasize, it would appear that the Met-DNAs induce metastasis by upregulating, in some way, the gene for their common eector, osteopontin. Whether this regulation is cis or trans-acting through positive elements or sequestration of inhibitory transcription factors remains to be determined. The fact that the frequency of the original metastatic transforments was so high (Jamieson et al., 1990a,b) suggests that the position-independent trans-acting mechanism is the more likely explanation. The lack of correlation between levels of opn mRNA and % metastasis probably re¯ects that the mRNA levels have been measured in uncloned transfectants (except the C9-DNA lung metastatic line) with varying proportions of metastatic and nonmetastatic clones. No other transformation or cancer-related genes have been identi®ed as being over or underexpressed by our subtractive hybridisation experiments between the benign and metastatic cell lines and other oncogenes tested, EJ-ras-1, Polyoma virus Large T and Middle T Antigens (Jamieson et al., 1990b) and secreted forms of bFGF (Davies et al., 1996) all fail to induce metastasis in this system. Formal proof for the intermediary role of osteopontin in the Met-DNAs' induction of metastatic ability will have to await inhibition of metastasizing ability by long-term suppression of osteopontin in Met-DNA transfectants, perhaps by further transfection with antisense expression vectors, but the interpretation of antisense eects are fraught with diculty.
Osteopontin is a secreted, calcium-binding phosphoprotein (Prince et al., 1987) originally implicated in bone remodelling (Reinholt et al., 1990 ) but now more widely thought of as an adhesion molecule acting through a highly conserved GRGDS amino acid sequence that can interact with a number of cell surface receptors including the a v b 3 integrin (vitronectin receptor) (Miyauchi et al., 1991; Felding-Hobermann et al., 1992 ). An elevated level of osteopontin has been correlated with tumour progression and metastasis (Denhardt and Gao, 1993) and reduction of its levels in metastatic cells by the use of antisense mRNA (Behrend et al., 1994; Gardner et al., 1994) and ribozyme technology (Feng et al., 1995) has resulted in a reduction of metastatic potential of transformed ®broblasts. Our results, however, demonstrate a direct eect of opn in inducing metastasis. It is possible that opn may function to reduce the sensitivity of the tumour cells to attack by cytotoxic host cells as reported in other systems (Feng et al., 1995) . However, the other molecule that induces metastasis in its transfectants in this rat mammary model is the intracellular calcium-binding protein p9Ka (Davies et al., 1993) . Expression of these two mRNAs is usually reciprocally related in spontaneously arising and induced metastatic tumours of the rat (Oates et al., 1996) . That p9Ka binds to the cellular cytoskeleton in vivo (Davies et al., 1993) and opn binds to a cell surface vitronectin receptor linked to the cytoskeleton (Reinholt et al., 1990; Miyauchi et al., 1991; FeldingHobermann et al., 1992) , and both molecules and the Met-DNAs increase the migratory activity of their transformants (Carroll J and Rudland PS, unpublished results) suggest that their mechanism of action in inducing metastasis may share common features centered on the cytoskeleton and migratory activity of the cell. The ®nding of dierent regulatory DNAs in human breast carcinoma cell lines and in some clinical specimens that control the expression of a common eector gene for the induction of metastasis provides a possible molecular mechanism for generating metastatic spread of some human cancers.
Materials and methods
Cell culture
The isolation of the benign rat mammary cell line Rama 37 (Dunnington et al., 1983) , the metastatic human carcinoma cell line Ca2-83 (Rudland et al., 1985) and the benign human breast cell line HMT-3522 (Briand et al., 1987) have been reported previously. The metastatic transformant, R37-Ca2-LT1 was produced by transfecting Rama 37 cells with restriction enzyme HindIII-digested Ca2-83 cellular DNA, injecting the resultant transformants into the mammary fat pad of syngeneic rats and then isolating the resulting cell line from a metastatic lung tumour (Davies et al., 1994) . The benign transformant R37-B-T1 was produced by transfecting Rama 37 cells with HindIIIdigested HMT-3522 nuclear DNA, injecting the resultant transformants into the rat mammary fat pads and then isolating the resultant cell line from the benign primary tumour (Davies et al., 1994) . KP1-LNT1 was a metastatic cell line cultured from cells of a metastatic lymph node tumour produced by transfectants derived by transfection of Rama 37 cells with the gene for p9Ka (Davies et al., 1993) . Cell lines were cultured in Dulbecco's modi®ed Eagles medium, 5% foetal calf serum (v/v), 50 ng/ml hydrocortisone, 50 ng/ml insulin as described previously (Dunnington et al., 1983) .
Tagging of fragmented DNA and its recovery Cellular DNA was digested completely with HindIII yielding fragments from 2 ± 23 kbp as described previously (Davies et al., 1994) . The double-stranded synthetic oligonucleotide tag (Figure 1a ) was covalently joined to both ends of HindIII-generated DNA fragments from metastatic R37-Ca2-LT1 and from benign R37-B-T1 cells using bacteriophage T4 ligase in a molar excess of 20 : 1. The unreacted tag DNA was separated by gel electrophoresis and the tagged DNA fragments were extracted from the low-melting agarose using a gene-clean kit (Biol01 Inc., USA). High-molecular-weight cellular DNA (Davies et al., 1994) from ®rst round transfectants produced by tagged and untagged HindIII fragments of DNA was ampli®ed by PCR using a short oligonucleotide primer of 22 bp (longer primers were predicted to oligomerise), corresponding to residues 3 ± 25 of the tag, for 30 cycles at 948C for 45 s, 558C for 30 s and 708C for 90 s, and the ampli®ed products separated on a 0.8% agarose gel. Those fragments of DNA that were speci®cally ampli®ed in the tagged metastatic transfectants of R37-Ca2-HT, termed F1 and F2 (which were equivalent to those from its derivative cell line isolated from a metastasis), were excised from the gel, pooled and cloned directly using a T-tailed vector (Marchuk et al., 1990) made by adding a single TMP to the 3' end of pBluescript vector (Barraclough et al., 1987) linearised by digestion with SmaI.
DNA transfection and metastasis
Donor cellular DNAs were fragmented by digestion with restriction enzyme HindIII and 22.5 mg/ml cotransfected with 2.5 mg/ml pSV2neo into exponentially-growing cultures of 10 6 Rama 37 cells per 9 cm petri dish via precipitation with calcium phosphate, exactly as described previously (Jamieson et al., 1990a; Davies et al., 1994) . Short donor DNA fragments F1 and F2, and Met-DNAs were puri®ed on 0.8% agarose gels, excised as above, concentrated by precipitation with ethanol and 22.5 mg/ml transfected with 2.5 mg/ml pSV2neo. The full length 1.5 kbp opn cDNA (clone 1.4) of Oates et al. (1996) was removed from pBluescript (SK7) with restriction enzymes XbaI and KpnI and ligated into the multiple cloning site of the pBKCMV vector before it was transfected at 5 mg/ml with 20 mg/ml salmon sperm DNA. Following all transfections the cells were passaged after 24 h at a dilution of 1 : 10 in medium containing 1 mg/ml Geneticin and transfectant colonies were pooled and expanded to give stocks for freezing (Jamieson et al., 1990a) . Pooled cells were harvested and 10 6 cells injected into the right inguinal mammary fat pads of 6-to 10-week old female FurthWistar rats (Ludwig-Wistar OLA strain) (Dunnington et al., 1983) . Rats were autopsied after 16 weeks and the relevant tissues ®xed in Methacarn prior to histological examination of ®ve microscopic ®elds from two sections by two independent observers (Jamieson et al., 1990a; Davies et al., 1994) . Tumour cells from metastases were reestablished in culture after disaggregation with collagenase as described previously (Jamieson et al., 1990a) and reinjected into rats to con®rm their metastatic properties (Davies et al., 1994) .
Detection of Met-DNA in transfectant cells and in clinical samples
Southern blotting was performed as follows for pBluescript clone 9 (C9-DNA) as an example. Cloned C9-DNA was ampli®ed by PCR using two synthetic, internal 17mer oligonucleotides from both ends of C9-DNA to avoid amplifying the tag seqence and electrophoresed on a 0.8% low-melting temperature agarose gel. The band containing ampli®ed C9-DNA was cut from the gel and 25 ng of the C9-DNA was radioactively labelled by random-primed synthesis to a speci®c activity of 1.6610 9 d.p.m./mg before hybridising to 10 mg of HindIII-digested or EcoRI-digested cellular DNA or to 1.5 ng of C9-DNA run on 0.8% (w/v) agarose gels or separated on 0.8% (w/v) pulsed ®eld agarose gels (Biorad: 162-0137). The latter were chilled to 148C, and run at 6 V/cm (200 V) using a switch time of 1.3 s for 24 h in a model CHEF-DRII pulsed ®eld system (Biorad). The radioactive bands corresponding to hybridisation of the probe were detected by exposure to X-ray ®lm and quanti®ed by scanning the images using a Shimadzu CS9000 scanning desitometer. The clinical samples corresponded to those used previously for RNA hybridisations (Anandappa et al., 1994) . For detection of C9-DNA sequences in genomic DNA by PCR, internal primers were used with optimal conditions of 30 cycles at 958C for 45 s, 558C for 45 s and 728C for 90 s.
Detection of expressed mRNA
Total RNA was isolated from the cell lines (Jamieson et al., 1990b; Davies et al., 1994) , subjected to electrophoresis in 0.8% agarose gels containing formaldehyde (Sambrook et al., 1989) , transferred to nylon ®lters (Hybond-N) and ®xed with U.V. light. The ®lters were ®rst incubated with 5 ng/ml of [ 32 P]C9-DNA (as above) or 5 ng/ml of 32 Plabelled full length opn cDNA (sp. act. *10 9 d.p.m./mg) and subsequently with cloned cDNA corresponding to nonmuscle actin or to ribosomal protein 36B4 respectively, for standardisation purposes (Oates et al., 1996) . For hybridisation to C9-DNA a control of 10 pm of C9-cRNA was also included; this was synthesised by bacteriophage T7 RNA polymerase (Boeringer-Mannheim, Lewes, UK) using C9-DNA from above as template, according to the manufacturers instructions. Bound radioactive probe was visualised by autoradiography and quanti®ed by scanning the images using a Shimadzu CS9000 scanning densitometer. Levels of standardised mRNA were expressed relative to the standardised level found in Rama 37 cells (Oates et al., 1996) . Immunocytochemical detection of osteopontin protein was performed on histological sections with 1/500 dilution of polyclonal antiserum to rat opn as described previously (Oates et al., 1996) (kindly provided by Dr C Giachelli, University of Washington, Seattle, USA) and detected with a peroxidase-conjugated rabbit anti-goat secondary immunoglobulin. The sections were counterstained with Mayer's haemalum. Photographs were recorded with a Reichert Polyvar microscope using a Wratten 44 ®lter on Pan F ®lm (Jamieson et al., 1990a,b) .
